세계의 바이오서저리 시장 규모, 점유율, 성장 분석, 제품별, 용도별, 최종사용자별, 지역별 시장 규모, 점유율, 성장 분석 - 산업 예측(2024-2031년)
Biosurgery Market Size, Share, Growth Analysis, By Product (Bone-Graft Substitutes, Soft-Tissue Attachments), By Application (General Surgery, Gynecological Surgery), By End User (Hospitals, Clinics), By Region - Industry Forecast 2024-2031
상품코드:1566199
리서치사:SkyQuest
발행일:2024년 10월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
바이오서저리 시장 규모는 2022년 145억 6,000만 달러로 평가되었습니다. 2023년 155억 6,000만 달러에서 2031년 265억 4,000만 달러로 성장하고, 예측 기간(2024-2031년) 동안 6.9%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.
바이오서저리 세계 시장은 수술 방법의 발전과 최소침습 수술에 대한 선호도가 높아지면서 괄목할 만한 성장을 보이고 있습니다. 바이오서저리는 지혈제, 실란트, 연조직 복구 제품과 같은 생물학적 재료의 사용을 포함하며, 치유 과정을 강화하고 수술 결과를 개선하는 데 도움을 줍니다. 수술 건수 증가, 만성질환 유병률 증가, 노인 인구 증가 등 여러 요인이 이 시장의 성장에 기여하고 있습니다. 또한, 개인 맞춤형 의료 트렌드와 혁신적인 생물학적 제제 시장 개척은 시장 성장을 가속화하는 데 중요한 역할을 하고 있습니다. 그러나 엄격한 규제 기준과 바이오시술 제품과 관련된 높은 비용으로 인해 시장 확산에 걸림돌이 될 수 있는 문제에 직면해 있습니다. 이러한 장애물에도 불구하고, 세계 바이오서저리 시장은 첨단 수술 기술의 개발 및 상용화에 집중하는 기업들에게 큰 비즈니스 기회를 제공합니다.
Biosurgery Market size was valued at USD 14.56 billion in 2022 and is poised to grow from USD 15.56 billion in 2023 to USD 26.54 billion by 2031, growing at a CAGR of 6.9% in the forecast period (2024-2031).
The global biosurgery market is undergoing notable growth, driven by advancements in surgical methods and the rising preference for minimally invasive procedures. Biosurgery encompasses the use of biological materials like hemostatic agents, sealants, and soft tissue repair products, which aid in enhancing the healing process and improving surgical results. Several factors are contributing to the expansion of this market, including the increasing number of surgeries, the rising incidence of chronic diseases, and the growing elderly population. Additionally, the trend toward personalized medicine and the development of innovative biologic products are playing a key role in accelerating market growth. However, the market faces challenges due to stringent regulatory standards and the high costs associated with biosurgery products, which may hinder wider adoption. Despite these obstacles, the global biosurgery market offers significant opportunities for companies focused on creating and commercializing advanced surgical technologies.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biosurgery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Biosurgery Market Segmental Analysis
Global Biosurgery Market is segmented by Product, Application, End User, end user and region. Based on Product, the market is segmented into Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agents, Surgical Sealants & Adhesives, Adhesion Barriers, Staple-Line and Reinforcement Agents. Based on Application, the market is segmented into Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Urological Surgery, Thoracic Surgery, and Other Applications. Based on End User, the market is segmented into Hospitals, Clinics, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Drivers of the Global Biosurgery Market
A major factor fueling the growth of the global biosurgery market is the rising demand for minimally invasive surgical procedures. These products are commonly used in such surgeries due to their ability to reduce trauma, speed up recovery, and minimize scarring. As patients and surgeons increasingly favor less invasive techniques, the demand for biosurgery solutions continues to rise. Moreover, technological advancements, including the development of cutting-edge biomaterials and surgical sealants, are accelerating the market's expansion. These innovations are enhancing the effectiveness of biosurgery products, further boosting their adoption in various surgical applications.
Restraints in the Global Biosurgery Market
A significant challenge for the global biosurgery market is the strict regulatory requirements and prolonged approval processes for new products. Biosurgery products must undergo extensive testing, clinical trials, and meet stringent safety and efficacy standards. These regulatory demands can lead to delays in bringing new products to market and inflate development costs. Additionally, the complex regulatory environment can hinder manufacturers' ability to innovate and launch new offerings. The high costs of regulatory compliance and product development often create entry barriers, particularly for small and medium-sized companies, limiting their participation and slowing overall market growth.
Market Trends of the Global Biosurgery Market
A notable trend in the global biosurgery market is the increasing adoption of minimally invasive surgical procedures. These techniques provide multiple benefits compared to traditional open surgeries, such as smaller incisions, less scarring, quicker recovery, and fewer postoperative complications. Consequently, there is growing demand for biosurgical products tailored specifically for minimally invasive procedures. This trend is fueled by the rising preference among patients and healthcare providers for less invasive treatments that deliver comparable or improved outcomes. In response, manufacturers in the biosurgery market are focusing on developing innovative products and techniques to meet this demand and improve patient satisfaction.
